Including results for celyad investor relations
Search only for cyad investor relations
Investors · Corporate Profile · Financial Calendar · Investors Kit · Upcoming Events · Latest Financial News · Footer ...
Letter to Shareholders 2024 · Celyad Oncology reports full year 2023 financial results and recent business highlights · Celyad Oncology announces intention to ...
Missing: cyad relations
Apr 4, 2024 · Celyad Oncology, today announces its financial results for the fiscal year 2023 ended December 31, 2023, and provides a business update.
Investor Relations – Filings and financial statements from Celyad Oncology SA. Check out the latest publications, news and insider trades.
View the latest Celyad Oncology S.A. (CYAD) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Missing: relations | Show results with:relations
Investor and Media Contacts: Sara Zelkovic. Communications & Investor Relations Director. Celyad Oncology. investors@celyad.com. Daniel Ferry. Managing Director.
People also search for
Celyad Oncology - ADR (US:CYAD) has 2 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC) ...
Aug 5, 2022 · ... Earnings Conference Call August 5, 2022 8:00 AM ET. Company Participants. Sara Zelkovic - Director, Communications and Investor Relations
Find the latest Celyad Oncology SA (CYAD.BR) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Financial Summary of Celyad Oncology SA(CYAD), Celyad Oncology SA, a clinical ... Investor Relations Michel Lussier - Interim Chief Executive Officer Charlie ...